KEGG   DRUG: Pegdinetanib
Entry
D09945                      Drug                                   
Name
Pegdinetanib (USAN/INN)
Formula
C468H729N125O139S
Exact mass
10356.3539
Mol weight
10362.62
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
  DG01917  Receptor tyrosine kinase inhibitor
Efficacy
Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor
Comment
PEGylated peptide
angiogenesis inhibitor
Target
VEGFR2 (KDR) [HSA:3791] [KO:K05098]
  Pathway
hsa04370  VEGF signaling pathway
hsa04510  Focal adhesion
Interaction
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG01918  Tyrosine kinase inhibitor
   DG01917  Receptor tyrosine kinase inhibitor
    D09945  Pegdinetanib
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   VEGFR family
    VEGFR2 (KDR)
     D09945  Pegdinetanib (USAN/INN)
Other DBs
CAS: 906450-24-6
PubChem: 124490627
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system